Martingale Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,492
Closed -$1.64M 1066
2019
Q3
$1.64M Hold
16,492
0.02% 643
2019
Q2
$1.52M Hold
16,492
0.02% 661
2019
Q1
$1.56M Sell
16,492
-600
-4% -$52.5K 0.02% 665
2018
Q4
$1.1M Sell
17,092
-6,005
-26% -$443K 0.01% 696
2018
Q3
$2.07M Sell
23,097
-7,104
-24% -$628K 0.02% 542
2018
Q2
$2.4M Sell
30,201
-3,199
-10% -$266K 0.03% 492
2018
Q1
$2.98M Sell
33,400
-1,200
-3% -$115K 0.04% 424
2017
Q4
$3.61M Buy
34,600
+1,299
+4% +$147K 0.05% 372
2017
Q3
$4.86M Buy
33,301
+16,823
+102% +$2.29M 0.07% 317
2017
Q2
$2.14M Sell
16,478
-22,727
-58% -$2.78M 0.03% 527
2017
Q1
$4.88M Sell
39,205
-30,272
-44% -$3.62M 0.07% 299
2016
Q4
$8.04M Sell
69,477
-4,502
-6% -$501K 0.11% 208
2016
Q3
$7.73M Sell
73,979
-1,868
-2% -$202K 0.12% 212
2016
Q2
$7.48M Buy
75,847
+4,679
+7% +$484K 0.12% 215
2016
Q1
$7.12M Sell
71,168
-2,831
-4% -$292K 0.14% 203
2015
Q4
$8.86M Buy
73,999
+3,155
+4% +$365K 0.2% 172
2015
Q3
$7.66M Sell
70,844
-2,588
-4% -$321K 0.19% 176
2015
Q2
$8.5M Sell
73,432
-13,203
-15% -$1.51M 0.2% 168
2015
Q1
$9.99M Buy
86,635
+5,326
+7% +$636K 0.24% 137
2014
Q4
$9.1M Buy
81,309
+14,000
+21% +$1.48M 0.25% 126
2014
Q3
$6.38M Sell
67,309
-204
-0.3% -$18.4K 0.2% 159
2014
Q2
$5.8M Sell
67,513
-10,177
-13% -$774K 0.18% 165
2014
Q1
$5.42M Sell
77,690
-598
-0.8% -$47.4K 0.18% 160
2013
Q4
$6.62M Sell
78,288
-5,298
-6% -$419K 0.23% 128
2013
Q3
$6.44M Buy
83,586
+3,532
+4% +$248K 0.23% 138
2013
Q2
$4.68M Buy
+80,054
New +$4.82M 0.17% 162

Other funds holding CELG

Martingale Asset Management's CELG Position: Q4 2019 in Review

Martingale Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,492 shares — an estimated $1.64M sold.

Martingale Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $9.99M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Martingale Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Martingale Asset Management sold 16,492 Celgene Corp shares in Q4 2019, an estimated $1.64M.
  • Martingale Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Martingale Asset Management's Celgene Corp position peaked at $9.99M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Martingale Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.